CDC Recommends RSV Vaccine for Older Adults

The CDC now recommends two new Respiratory Syncytial Virus (RSV) vaccines for adults age 60 and up. Adults at the highest risk for severe RSV illness include older adults, adults with chronic heart or lung disease, adults with weakened immune systems, and adults living in nursing homes or long-term care facilities. CDC estimates that every year, RSV causes approximately 60,000–160,000 hospitalizations and 6,000–10,000 deaths among older adults. The single-dose vaccines, one developed by Pfizer and the other developed by GSK, are expected to be available to the public this fall. Read more from the CDC here.